ENVERIC BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Other
ENVERIC BIOSCIENCES, INC. (ENVB) reported Adjustments to Additional Paid in Capital, Other of $1.24 million for the 12-month period ending 2018-12-31, per its 10-K/A filed 2020-08-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2020-08-12
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, other for fiscal 2018 was $1.24M.
| Period end | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|
| 2018-12-31 | $1.24M 10-K/A · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |